Are there MAO inhibitors specific for dopamine metabolism?
D000818:Animals; D001665:Binding Sites / Q000187:drug effects; D001921:Brain / Q000201:enzymology; D003010:Clorgyline / Q000494:pharmacology; D004298:Dopamine / Q000378:metabolism*; D004357:Drug Synergism; D006801:Humans; D066298:In Vitro Techniques; D007980:Levodopa / Q000627:therapeutic use; D008099:Liver / Q000201:enzymology; D008995:Monoamine Oxidase / Q000378:metabolism; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy; D010627:Phenethylamines / Q000494:pharmacology / Q000627:therapeutic use
D008996:Monoamine Oxidase Inhibitors; D010627:Phenethylamines; D007980:Levodopa; D008995:Monoamine Oxidase; D003010:Clorgyline; D004298:Dopamine